Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Ema entities : Glaxosmithkline plc save search
Hematological Malignancies Emerging Therapeutics - A Global Industry Assessment with Insights & Projections by Therapeutic Type, Potential Pipeline Products, Indication, and Region, 2021-2031
Published: 2022-03-16 (Crawled : 14:30) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 0
|
Health Technology
|
| O: -0.46%
H: 3.49%
C: 3.49%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 2.07%
H: 1.62%
C: 1.56%
JNJ | News | $148.53 -0.69% 0.11% 67K
|
Health Technology
|
| O: 1.23%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% 0.91% 11K
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
BMY | $48.86 -0.27% 0.98% 14M
|
Health Technology
|
| O: 0.26%
H: 0.31%
C: -0.39%
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: 0.4%
H: 0.2%
C: -0.29%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
GILD | $67.08 0.08% 0.06% 2.5K
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: -1.19%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: -0.37%
ema therapeutics potential
Hematological Malignancies Drugs Market worth $ 42.78 Billion by 2030 - Exclusive Report by InsightAce Analytic
Published: 2022-03-08 (Crawled : 11:00) - prnewswire.com
GNMSF | News | $290.34 0.23% 3.83% 0
|
Health Technology
|
| O: -0.14%
H: 5.36%
C: 5.36%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -2.75%
H: 0.28%
C: -1.04%
JNJ | News | $148.53 -0.69% 0.11% 67K
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% 0.91% 11K
|
Health Technology
|
| O: 0.38%
H: 1.81%
C: 0.28%
BMY | $48.86 -0.27% 0.98% 14M
|
Health Technology
|
| O: -1.55%
H: 0.71%
C: -0.28%
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: 0.29%
H: 0.6%
C: -1.24%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
GILD | $67.08 0.08% 0.06% 2.5K
|
Health Technology
|
| O: 1.4%
H: 0.7%
C: -1.15%
GMAB | News | $28.47 -0.32% -0.32% 420
|
Health Technology
|
| O: -0.3%
H: 3.38%
C: 0.32%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
ema drug report
Stem Cells Market To Grow At A CAGR Of 7.9%| Increasing demand for regenerative medicine augment the market growth: Growth Plus Reports
Published: 2021-10-27 (Crawled : 06:00) - prnewswire.com
ALPMF | News | $9.5 -2.56% 43.47% 6.8K
|
Health Technology
|
| O: 2.04%
H: 0.0%
C: 0.0%
GLAXF | News | $19.54 -3.77% -14.18% 0
|
Health Technology
|
| O: 0.31%
H: 2.03%
C: 1.43%
ALPMY | News | $9.47 -0.21% -1.11% 20K
|
Manufacturing
|
| O: -0.61%
H: 0.73%
C: 0.24%
SANA | $8.58 6.06% 5.71% 1.2M
|
|
| O: -0.42%
H: 1.42%
C: -2.8%
GSK | News | $40.86 -0.92% 0.91% 11K
|
Health Technology
|
| O: 1.07%
H: 0.67%
C: 0.3%
ema stem cell growth
CORRECTION -- EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For the Early Treatment of COVID-19
Published: 2021-05-21 (Crawled : 14:00) - globenewswire.com
GSK | News | $40.86 -0.92% 0.91% 11K
|
Health Technology
|
| O: -0.26%
H: 0.26%
C: -0.21%
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: -0.06%
VIR | $8.04 -1.11% -1.12% 770K
|
Health Technology
|
| O: 1.75%
H: 0.13%
C: -1.44%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
covid treatment positive biotech technology iot ema
EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For the Early Treatment of COVID-19
Published: 2021-05-21 (Crawled : 12:15) - globenewswire.com
GSK | News | $40.86 -0.92% 0.91% 11K
|
Health Technology
|
| O: -0.26%
H: 0.26%
C: -0.21%
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: -0.06%
VIR | $8.04 -1.11% -1.12% 770K
|
Health Technology
|
| O: 1.75%
H: 0.13%
C: -1.44%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
covid treatment positive biotech technology iot ema
GSK and Vir Biotechnology Announce the Start of the EMA Rolling Review of VIR-7831 (sotrovimab) for the Early Treatment of COVID-19
Published: 2021-05-07 (Crawled : 14:00) - biospace.com/
GSK | News | $40.86 -0.92% 0.91% 11K
|
Health Technology
|
| O: 0.5%
H: 0.84%
C: 0.66%
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: 0.48%
H: 0.74%
C: 0.31%
VIR | $8.04 -1.11% -1.12% 770K
|
Health Technology
|
| O: 3.24%
H: 2.94%
C: 0.02%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.92%
H: 0.88%
C: 0.66%
covid treatment biotech technology iot ema
GSK and Vir Biotechnology Announce EMA Review of Dual-Action Monoclonal Antibody VIR-7831 for the Early Treatment of COVID-19
Published: 2021-04-15 (Crawled : 14:00) - globenewswire.com
GSK | News | $40.86 -0.92% 0.91% 11K
|
Health Technology
|
| O: 4.23%
H: 1.59%
C: 0.08%
VIR | $8.04 -1.11% -1.12% 770K
|
Health Technology
|
| O: 0.37%
H: 2.8%
C: -1.49%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.76%
H: 0.61%
C: 0.14%
covid treatment antibody biotech technology iot ema
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 1.2M
|
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.